Open AccessEffect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia
Author(s) -
Jeffrey L. Cummings,
Constantine G. Lyketsos,
Elaine R. Peskind,
Anton P. Porsteinsson,
Jacobo Mintzer,
Douglas W. Scharre,
José E. De La Gándara,
Marc Agronin,
Charles S. Davis,
Uyen Nguyen,
Paul Shin,
Pierre N. Tariot,
João Siffert
Publication year - 2015
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2015.10214
Subject(s) - dextromethorphan , medicine , placebo , quinidine , tolerability , anesthesia , psychomotor agitation , adverse effect , alternative medicine , pathology
Agitation is common among patients with Alzheimer disease; safe, effective treatments are lacking.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom